Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology. more
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -1.5% | 0.01% |
| 1-Month Return | 6.14% | 3.54% |
| 3-Month Return | 10.78% | 10.58% |
| 6-Month Return | 5.91% | 8.03% |
| 1-Year Return | 19.74% | 20.06% |
| 3-Year Return | 15.71% | 70.98% |
| 5-Year Return | 4.2% | 71.89% |
| 10-Year Return | 105.22% | 252.66% |
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -54.53% | 0.52% |
| 1-Month Return | 106.47% | 52.69% |
| 3-Month Return | 51.47% | 50.36% |
| 6-Month Return | 12.35% | 16.96% |
| 1-Year Return | 19.74% | 20.06% |
| 3-Year Return | 4.98% | 19.58% |
| 5-Year Return | 0.83% | 11.44% |
| 10-Year Return | 7.45% | 13.43% |
| Stock name | Ticker | Weight |
|---|---|---|
Guardant Health, Inc.
|
GH |
2.51%
|
Regeneron Pharmaceuticals, Inc.
|
REGN |
2.46%
|
The Cigna Group
|
CI |
2.43%
|
Boston Scientific Corporation
|
BSX |
2.42%
|
Centene Corporation
|
CNC |
2.42%
|
Universal Health Services, Inc. (Class B)
|
UHS |
2.4%
|
Natera, Inc.
|
NTRA |
2.39%
|
Zimmer Biomet Holdings, Inc.
|
ZBH |
2.38%
|
Medline Inc. (Class A)
|
MDLN |
2.38%
|
DaVita Inc.
|
DVA |
2.37%
|
Axsome Therapeutics, Inc.
|
AXSM |
2.34%
|
Pfizer Inc.
|
PFE |
2.31%
|
Solventum Corporation
|
SOLV |
2.26%
|
Globus Medical, Inc. (Class A)
|
GMED |
2.23%
|
Tenet Healthcare Corporation
|
THC |
1.9%
|
Encompass Health Corporation
|
EHC |
1.88%
|
Elevance Health Inc.
|
ELV |
1.86%
|
QIAGEN N.V.
|
QGEN |
1.84%
|
Corcept Therapeutics Inc.
|
CORT |
1.84%
|
Neurocrine Biosciences, Inc.
|
NBIX |
1.84%
|
ResMed Inc.
|
RMD |
1.83%
|
Medtronic Plc
|
MDT |
1.81%
|
Incyte Corporation
|
INCY |
1.79%
|
Zoetis Inc.
|
ZTS |
1.79%
|
Ascendis Pharma A/S
|
ASND |
1.77%
|
Arrowhead Pharmaceuticals, Inc.
|
ARWR |
1.77%
|
United Therapeutics Corporation
|
UTHR |
1.75%
|
Eli Lilly and Company
|
LLY |
1.74%
|
Halozyme Therapeutics, Inc.
|
HALO |
1.72%
|
Gilead Sciences, Inc.
|
GILD |
1.47%
|
Doximity, Inc. (Class A)
|
DOCS |
1.46%
|
Exelixis, Inc.
|
EXEL |
1.45%
|
Viatris Inc.
|
VTRS |
1.42%
|
Steris Plc
|
STE |
1.41%
|
Revolution Medicines, Inc.
|
RVMD |
1.41%
|
Medpace Holdings, Inc.
|
MEDP |
1.39%
|
GE HealthCare Technologies Inc.
|
GEHC |
1.39%
|
Bristol-Myers Squibb Company
|
BMY |
1.39%
|
Becton, Dickinson and Company
|
BDX |
1.37%
|
Labcorp Holdings Inc.
|
LH |
1.37%
|
Quest Diagnostics Incorporated
|
DGX |
1.35%
|
Biogen Inc.
|
BIIB |
1.27%
|
Ionis Pharmaceuticals, Inc.
|
IONS |
1.12%
|
BridgeBio Pharma, Inc.
|
BBIO |
1.04%
|
IQVIA Holdings Inc.
|
IQV |
0.93%
|
Veeva Systems Inc. (Class A)
|
VEEV |
0.92%
|
Tempus AI, Inc. (Class A)
|
TEM |
0.91%
|
Align Technology, Inc.
|
ALGN |
0.91%
|
Chemed Corporation
|
CHE |
0.9%
|
HCA Healthcare, Inc.
|
HCA |
0.9%
|
Thermo Fisher Scientific Inc.
|
TMO |
0.9%
|
Madrigal Pharmaceuticals, Inc.
|
MDGL |
0.89%
|
Abbott Laboratories
|
ABT |
0.89%
|
Agilent Technologies, Inc.
|
A |
0.86%
|
Henry Schein, Inc.
|
HSIC |
0.86%
|
Vertex Pharmaceuticals Incorporated
|
VRTX |
0.86%
|
Organon & Co.
|
OGN |
0.85%
|
AbbVie Inc.
|
ABBV |
0.85%
|
Illumina, Inc.
|
ILMN |
0.47%
|
DexCom, Inc.
|
DXCM |
0.46%
|
IDEXX Laboratories, Inc.
|
IDXX |
0.46%
|
The Ensign Group, Inc.
|
ENSG |
0.45%
|
BioMarin Pharmaceutical Inc.
|
BMRN |
0.45%
|
Stryker Corporation
|
SYK |
0.45%
|
Danaher Corporation
|
DHR |
0.44%
|
Johnson & Johnson
|
JNJ |
0.44%
|
Revvity, Inc.
|
RVTY |
0.44%
|
Bio-Rad Laboratories, Inc. (Class A)
|
BIO |
0.43%
|
Amgen Inc.
|
AMGN |
0.43%
|
West Pharmaceutical Services, Inc.
|
WST |
0.43%
|
The Cooper Companies, Inc.
|
COO |
0.42%
|
Envista Holdings Corporation
|
NVST |
0.42%
|
Merck & Co., Inc.
|
MRK |
0.42%
|
US Dollar
|
.USD |
0.19%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
First Trust Health Care AlphaDEX® Fund (FXH) share price today is $123.93.
Yes, Indians can buy shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. To buy FXH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. You can start investing in First Trust Health Care AlphaDEX® Fund (FXH) with a minimum investment of $1.
The 52-week high price of First Trust Health Care AlphaDEX® Fund (FXH) is $127.53. The 52-week low price of First Trust Health Care AlphaDEX® Fund (FXH) is $96.62.
The stock symbol (or ticker) of First Trust Health Care AlphaDEX® Fund is FXH.
Yes, you can setup SIP in First Trust Health Care AlphaDEX® Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of FXH on the Vested app.
The expense ratio of First Trust Health Care AlphaDEX® Fund (FXH) is 0.62%.
Link copied